PaThERAS: ERAS Protocols in Thyroid & Parathyroid Surgery
PaThERAS
PaThERAS Study- Application of Enhanced Recovery After Surgery Protocols in Thyroid and Parathyroid Surgery
1 other identifier
interventional
96
1 country
1
Brief Summary
Enhanced recovery after surgery (ERASP) are evidence-based perioperative protocols devised to expedite postoperative recovery and discharge, decrease surgical stress and costs. However, there is limited data on their use and effectiveness in thyroid and parathyroid surgery. Aim of PaThERAS study is to investigate the clinical benefits and cost-effectiveness of enhanced recovery protocols for the perioperative management in patients undergoing total thyroidectomy for large goiters/ cancers and parathyroidectomy for symptomatic hyperparathyroidism in non-day-care setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2023
CompletedFirst Submitted
Initial submission to the registry
January 16, 2024
CompletedFirst Posted
Study publicly available on registry
February 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2024
CompletedJanuary 7, 2025
January 1, 2025
1.7 years
January 16, 2024
January 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the rate of hypocalcemia in patients undergoing thyroid and parathyroid surgery implementing Enhanced recovery after surgery protocols vs Conventional peri operative protocols
S. Calcium levels will be measured. Levels \>8mg/dl were considered normal
Post operative day 1, 2 & 7
Secondary Outcomes (4)
To compare length of hospital stay in patients undergoing thyroid and parathyroid surgery in days
from date of surgery till Post operative Day 7
To compare hospital costs in patients undergoing thyroid and parathyroid surgery implementing Enhanced recovery after surgery protocols vs Conventional peri operative protocols
from date of surgery till Post operative Day 7
To compare postoperative complication rates in patients undergoing thyroid and parathyroid surgery implementing Enhanced recovery after surgery protocols vs Conventional peri operative protocols
from date of surgery till 6 months post surgery
To compare readmission rate
from date of surgery till 6 months post surgery
Study Arms (2)
ERAS Group
EXPERIMENTALThose patients who follow ERAS protocols preoperatively, intraoperatively and post operatively
Conventional Group
ACTIVE COMPARATORThose patients who conventional protocols preoperatively, intraoperatively and post operatively
Interventions
Conventional protocols for non-ERASP group Eg: No preoperative vitamin D and calcium supplementation etc.
Eligibility Criteria
You may qualify if:
- Patients diagnosed to have ASA Grade 1 and Grade 2 patients with thyroid and/or parathyroid (1° and 2° hyperparathyroidism) disease undergoing the following procedures via open or endoscopic approach • Total thyroidectomy/Focused parathyroidectomy/BNE with excision of enlarged glands +/- any additional procedure (Eg: Central compartment neck dissection, Lateral neck dissection, Cervical thymectomy etc)
You may not qualify if:
- Patients undergoing thyroid and/or parathyroid surgery who
- Undergo hemithyroidectomy
- Refuse to consent to participate in the study in the cohort group
- ASA Grade 3 and Grade 4\* \*Comorbidities of severe nature which may independently impact perioperative hospital stay, complications and outcomes in the study and control group
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Lucknow, Uttar Pradesh, 226014, India
Related Publications (6)
Chorath K, Luu N, Go BC, Moreira A, Rajasekaran K. ERAS Protocols for Thyroid and Parathyroid Surgery: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2022 Mar;166(3):425-433. doi: 10.1177/01945998211019671. Epub 2021 Jun 15.
PMID: 34126805BACKGROUNDSmith TW Jr, Wang X, Singer MA, Godellas CV, Vaince FT. Enhanced recovery after surgery: A clinical review of implementation across multiple surgical subspecialties. Am J Surg. 2020 Mar;219(3):530-534. doi: 10.1016/j.amjsurg.2019.11.009. Epub 2019 Nov 16.
PMID: 31761300BACKGROUNDDort JC, Farwell DG, Findlay M, Huber GF, Kerr P, Shea-Budgell MA, Simon C, Uppington J, Zygun D, Ljungqvist O, Harris J. Optimal Perioperative Care in Major Head and Neck Cancer Surgery With Free Flap Reconstruction: A Consensus Review and Recommendations From the Enhanced Recovery After Surgery Society. JAMA Otolaryngol Head Neck Surg. 2017 Mar 1;143(3):292-303. doi: 10.1001/jamaoto.2016.2981.
PMID: 27737447BACKGROUNDTerris DJ, Snyder S, Carneiro-Pla D, Inabnet WB 3rd, Kandil E, Orloff L, Shindo M, Tufano RP, Tuttle RM, Urken M, Yeh MW; American Thyroid Association Surgical Affairs Committee Writing Task Force. American Thyroid Association statement on outpatient thyroidectomy. Thyroid. 2013 Oct;23(10):1193-202. doi: 10.1089/thy.2013.0049. Epub 2013 Sep 14.
PMID: 23742254BACKGROUNDXing T, Hu Y, Wang B, Zhu J. Role of oral calcium supplementation alone or with vitamin D in preventing post-thyroidectomy hypocalcaemia: A meta-analysis. Medicine (Baltimore). 2019 Feb;98(8):e14455. doi: 10.1097/MD.0000000000014455.
PMID: 30813146BACKGROUNDKhatiwada AS, Harris AS. Use of pre-operative calcium and vitamin D supplementation to prevent post-operative hypocalcaemia in patients undergoing thyroidectomy: a systematic review. J Laryngol Otol. 2021 Jul;135(7):568-573. doi: 10.1017/S0022215121001523. Epub 2021 Jun 14.
PMID: 34120662BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gaurav Agarwal, MS
gauravbsi@gmail.com
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Head of Department Endocrine and Breast Surgery
Study Record Dates
First Submitted
January 16, 2024
First Posted
February 23, 2024
Study Start
January 25, 2023
Primary Completion
September 25, 2024
Study Completion
September 25, 2024
Last Updated
January 7, 2025
Record last verified: 2025-01